CLGN
NASDAQ · Biotechnology
Collplant Biotechnologies Lt
$3.79
-0.08 (-2.07%)
Open$3.94
Previous Close$3.87
Day High$3.94
Day Low$3.68
52W High$31.80
52W Low$2.64
Volume—
Avg Volume108.7K
Market Cap7.79M
P/E Ratio—
EPS$-7.78
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+353.6% upside
Current
$3.79
$3.79
Target
$17.19
$17.19
$14.35
$17.19 avg
$29.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.70M | 1.86M | 1.91M |
| Net Income | -17,932,087 | -8,102,253 | 134.3K |
| Profit Margin | -484.6% | -460.3% | 7.0% |
| EBITDA | -16,499,188 | -7,868,983 | 222.2K |
| Free Cash Flow | — | — | 168.1K |
| Rev Growth | +99.2% | +99.2% | +10.4% |
| Debt/Equity | — | — | 0.39 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.29 | -1.12% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $423.64 | +1.32% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $151.28 | -0.61% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $526.73 | -0.18% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $750.51 | -0.23% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $254.07 | -0.51% | 41.4 | 33.44B |